Literature DB >> 26173576

Patients of all ages with advanced non-small cell lung cancer are not receiving chemotherapy.

Mary Kay Barton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26173576     DOI： 10.3322/caac.21290

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN： 0007-9235            Impact factor:   508.702


× No keyword cloud information.
  5 in total

1.  Pregnane X receptors regulate CYP2C8 and P-glycoprotein to impact on the resistance of NSCLC cells to Taxol.

Authors:  Yan Chen; Wandan Huang; Feiyu Chen; Guoping Hu; Fenglei Li; Jianhua Li; Aiguo Xuan
Journal:  Cancer Med       Date:  2016-11-22       Impact factor: 4.452

2.  Clinical investigation into the initial diagnosis and treatment of 539 patients with stage IV lung cancer.

Authors:  Qian Shao; Shanshan Liu; Wei Wang; Yingjie Zhang; Fengxiang Li; Jianbin Li
Journal:  Onco Targets Ther       Date:  2017-01-31       Impact factor: 4.147

3.  Expression of GOLPH3 in patients with non-small cell lung cancer and xenografts models.

Authors:  Shicong Tang; Rirong Yang; Xin Zhou; Hong Pan; Jianlun Liu
Journal:  Oncol Lett       Date:  2018-03-23       Impact factor: 2.967

4.  Influence of thoracic drainage fluid on proliferation, migration, apoptosis, and drug resistance in lung cancer cell lines.

Authors:  Yuqiang Mao; Ying Yu; Yun Han
Journal:  Cancer Manag Res       Date:  2019-03-20       Impact factor: 3.989

5.  Randomized and dose-escalation trials of recombinant human serum albumin /granulocyte colony-stimulating factor in patients with breast cancer receiving anthracycline-containing chemotherapy.

Authors:  Shanshan Chen; Yiqun Han; Quchang Ouyang; Jianguo Lu; Qingyuan Zhang; Shun'e Yang; Jingfen Wang; Haixin Huang; Hong Liu; Zhimin Shao; Hui Li; Zhendong Chen; Sanyuan Sun; Cuizhi Geng; Junguo Lu; Jianwei Sun; Jiayu Wang; Binghe Xu
Journal:  BMC Cancer       Date:  2021-03-31       Impact factor: 4.430
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.